Related Experiment Video
Updated: Aug 14, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Insulin-like growth factor-I and mineral metabolism markers in children with idiopathic decrease in bone mass
Agnieszka Rusińska1, Danuta Chlebna-Sokół
1Department of Paediatric Propedeutics and Bone Metabolic Diseases, Medical University of Łódź 36/50 Sporna St., 91-738 Łódź, Poland.
Insights
Children with osteoporosis and osteopenia have lower insulin-like growth factor-I (IGF-I) levels, indicating its role in idiopathic bone mass loss. This finding highlights IGF-I as a potential marker for pediatric bone health.
Area of Science:
- Pediatric Endocrinology
- Bone Metabolism
- Growth Factors
Background:
- Idiopathic decrease in bone mass is a concern in children.
- Insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are crucial for bone development.
- The relationship between IGF-I, IGFBP-3, and mineral metabolism in pediatric bone disorders requires further elucidation.
Purpose of the Study:
- To investigate the correlation between serum IGF-I and IGFBP-3 concentrations and mineral metabolism markers.
- To assess the role of IGF-I in children with idiopathic osteoporosis and osteopenia.
Main Methods:
- Serum IGF-I and IGFBP-3 levels were measured in 62 children (aged 6-18) with idiopathic osteoporosis/osteopenia and 20 controls.
- Bone mineral density was assessed using densitometry.
- Urinary markers of bone resorption (pyridinoline and deoxypyridinoline) were analyzed.
Main Results:
- Children with osteoporosis and osteopenia exhibited significantly lower mean IGF-I concentrations compared to controls.
- IGF-I levels positively correlated with total and spinal bone mineral density.
- In osteoporotic children, IGF-I showed a significant relationship with urinary pyridinoline and deoxypyridinoline.
Conclusions:
- Reduced serum IGF-I concentrations are associated with decreased bone mineral density and increased bone resorption in children.
- These findings suggest that IGF-I plays a significant role in the pathogenesis of idiopathic bone mass reduction in pediatric populations.
Objective:
The aim of the study was to determine whether the serum concentration of insulin-like growth factor-I (IGF-I) and its binding protein-3 (IGFBP-3) correlates with the mineral metabolism markers in children with idiopathic decrease in bone mass.
Patients And Methods:
The study comprised 62 patients aged 6-18 years, including 42 with idiopathic decrease in bone mineral density (20 with osteoporosis and 22 with osteopenia) and 20 control children. Osteoporosis and osteopenia were diagnosed on the basis of complex clinical, densitometric and biochemical examinations (in all patients secondary causes of the decreased bone mass were excluded). Serum concentration of IGF-I was determined with radioimmunoassay and IGFBP-3 using immunoradiometry.
Results:
The children with osteoporosis and osteopenia were found to have mean IGF-I concentration statistically significantly lower than the controls (548 and 645 v. 819 ng/ml, respectively; p<0.05). Moreover, IGF-I correlated positively with total and spinal bone mineral density. In children with osteoporosis there was also a significant relationship between IGF-I and pyridinoline and deoxypyridinoline in urine.
Conclusions:
Lower serum IGF-I concentration together with higher bone resorption and low bone mineral density reveal involvement of this growth factor in the development of idiopathic decrease of bone mass in children.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Skeleton and Calcium Homeostasis
Nature and Nurture